AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Sep 18, 2012
30016_dirs_2012-09-18_00df46ff-a275-4ba0-abac-35847c1d1180.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-09-14
Reporting Person: CRAIG THOMAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-14 | Common Stock | M | 8000 | $17.49 | Acquired | 18917 | Direct |
| 2012-09-14 | Common Stock | S | 8000 | $99.29 | Disposed | 10917 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-14 | Non-Qualified STock Option (right to buy) | $17.49 | M | 8000 | Disposed | 2013-05-21 | Common Stock (8000) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $98.95 to $99.52, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Grant of options to buy shares of common stock that vest one year from the date of grant 05/21/2003.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13